Annuities
PR Newswire | January 10, 2024
New York Life Investment Management ("NYLIM") today announced a strategic partnership with Bow River Advisers, a subsidiary of Bow River Capital. The partnership combines NYLIM's distribution and client service strengths, with Bow River Advisers' expertise in private markets investing and portfolio management. With this new agreement, NYLIM will take a minority interest in Bow River Advisers and serve as distribution partner for the Bow River Capital Evergreen Fund ("EVERX" or "the Fund"), a fund that provides access to a diversified portfolio of private equity investments.
"New York Life Investment Management has been committed to providing quality alternative investment solutions to our clients for more than two decades," said New York Life Investment Management Chief Operating Officer Kirk Lehneis. "This partnership with Bow River Advisers, an innovator in providing high-quality private equity exposure in an investor-friendly structure, will allow us to provide a more differentiated product offering to our clients, while providing additional support to the Fund's existing client base."
The Bow River Capital Evergreen Fund was launched in May 2020, and provides access to a broad range of private equity investments across sector, sponsor, geography and size. The Fund's combination of immediate investment exposure, broad diversification and low investment minimums ($50,000 for accredited investors) has attracted interest from a wide range of investors, particularly those interested in diversifying their traditional stock and bond portfolios.
"We built the Bow River Capital Evergreen Fund to provide investors with what we believe is an easily accessible private equity portfolio," said Jeremy Held, Managing Director, Bow River Advisers and President of the Evergreen Fund. "Our partnership with New York Life Investment Management provides significant resources that will allow us to broaden the Fund's investor base while remaining focused on portfolio management and the Fund's day-to-day operations. As one of the largest and most well-respected institutional investors in the world, New York Life Investment Management will bring expertise that can enhance the reach of the Fund going forward."
NYLIM will provide distribution and marketing support to the Fund, and Bow River Capital Evergreen's investment strategy, team and day-to-day operations will remain unchanged.
About New York Life Investments
With over $687 billion in Assets Under Management as of September 30, 2023, New York Life Investments, Pensions and Investments' 25th Largest Money Manager, is comprised of the affiliated global asset management businesses of its parent company, New York Life Insurance Company, and offers clients access to specialized, independent investment teams through its family of affiliated boutiques. New York Life Investments remains committed to clients through a combination of the diverse perspectives of its boutiques and a long-lasting focus on sustainable relationships.
"New York Life Investments" is both a service mark, and the common trade name, of certain investment advisors affiliated with New York Life Insurance Company.
About Bow River Capital
Bow River Capital is a private alternative asset manager based in Denver, Colorado, focused on investing in the lower and middle market in four asset classes: private credit, private equity, real estate, and software growth equity. Through its subsidiary Bow River Advisers, LLC, Bow River Capital also offers a registered interval fund – Bow River Capital Evergreen Fund (EVERX) – designed to provide private market access to a broader set of investors.
Collectively, the Bow River Capital team has deployed capital into diverse industries, asset classes and across the capital structure.
Read More
Health Insurance
PR Newswire | January 09, 2024
Caris Life Sciences(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular science and AI, and Flatiron Health, a leading healthtech company transforming evidence generation through an engaged care network, oncology-specific expertise, and fit-for-purpose scientific methods and tools, today announced a partnership to create a multimodal data offering to support and accelerate biopharmaceutical drug development and patient care.
Combining the breadth and depth of Caris' genomic, transcriptomic and imaging database with Flatiron's industry-leading longitudinal patient data and high-quality clinical outcomes, backed by deep scientific expertise, equips cancer researchers with robust comprehensive real-world data (RWD) offering at scale to power the next wave of cancer therapeutics.
"We are excited to collaborate with Flatiron Health to create a multimodal data offering in support of biopharma's efforts to bring novel personalized therapeutic interventions to market to ultimately improve the lives of cancer patients," said David Spetzler, MS, PhD, MBA, President of Caris Life Sciences. "In forming this data union, we are able to maximize biological and clinical context to better understand each patient journey."
"We are thrilled to announce this groundbreaking partnership that brings together Caris' leading molecular science capabilities with Flatiron's unparalleled gold standard of high-quality oncology real-world data," said Stephanie Reisinger, Senior Vice President and General Manager, Real-World Evidence, Flatiron Health. "This opportunity has the potential to create the largest and best-in-class clinical-omics dataset with Whole Exome and Whole Transcriptome sequencing coverage, expanding our opportunity to support biopharma in the preclinical stages of drug discovery and translation."
"Identifying sufficient numbers of records to build cohorts of adequate size that can be used to address the most pressing research questions is a challenge that plagues the oncology community. With Caris and Flatiron's combined strength and broad reach across oncology, we can provide this incredibly powerful data at a scale that will fuel drug discovery and therapeutic innovation," said Brian Lamon, PhD, Chief Business Officer of Caris Life Sciences.
As the pioneer in precision medicine and molecular profiling, Caris has created a molecular-rich, real-world database that contains more than 50 petabytes of oncology-specific genomic, transcriptomic, proteomic and imaging data. Caris was the first in the molecular diagnostic industry to provide Whole Exome Sequencing DNA coverage and Whole Transcriptome Sequencing RNA coverage (WES / WTS) for every patient tested.
About Caris Life Sciences
Caris Life Sciences (Caris) is the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular science and AI. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced AI and machine learning algorithms, Caris has created the large-scale, clinico-genomic database and computing capability needed to analyze and unravel the molecular complexity of disease. This convergence of sequencing power, big data and AI technologies provides an unmatched platform to deliver the next-generation of precision medicine tools for early detection, diagnosis, monitoring, therapy selection and drug development.
Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S., Europe, Asia and other international markets.
About Flatiron Health
Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients' real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group.
Read More
Risk Management
PR Newswire | January 10, 2024
Specialty Program Group LLC (SPG), a leading operator of specialty insurance brokerage, underwriting and consulting facilities, announced today the acquisition of the assets of Disaster Recovery Services, LLC and its affiliate, Disaster Recovery & Risk Solutions, LLC (collectively, DRS), a premier provider of disaster preparation, response, and recovery consulting for commercial and public entities. Established with a commitment to aid organizations in their times of need, DRS brings to the table extensive experience in disaster preparedness planning and mitigation, real-time response coordination, forensic accounting and financial recovery services, particularly in responding to adverse events such as fires, floods, and hurricanes. DRS rounds out this comprehensive support with construction project management, grant administration, and procurement consulting.
"Partnering with DRS aligns perfectly with our mission to offer innovative and comprehensive solutions to our clients," said SPG President & CEO, Christopher Treanor. "DRS's expertise in disaster recovery not only complements our existing services but also strengthens our commitment to providing unparalleled support in times of crisis."
With its expertise in handling complex scenarios, DRS has established itself as a trusted partner in providing turnkey solutions throughout the recovery process, whether it involves commercial insurance recovery, FEMA reimbursement, construction project management, grant administration, procurement support, or mitigation and resiliency.
"Joining forces with SPG opens new avenues for growth and allows us to leverage their extensive network and resources," said DRS CEO, John Albrecht.
This acquisition aligns with SPG's strategic goal to diversify and strengthen its portfolio, extending its reach into the critical areas of disaster preparedness, mitigation, response, and recovery. The enhanced capabilities brought by DRS will help ensure SPG continues to meet the evolving needs of its clients and partners in an increasingly complex risk environment.
About Specialty Program Group
Specialty Program Group LLC (SPG) is a leading specialty platform headquartered in Chicago, IL, with a diverse portfolio of specialty insurance operations spanning underwriting management, digital solutions, wholesale and specialty retail brokerage, and insurance services. SPG has a track record of scaling industry leading businesses by providing access to business resources, technology and process efficiency, capital and investment, deep carrier relationships, and a broad distribution network.
About Disaster Recovery Services
Disaster Recovery Services, together with its affiliate, Disaster Recovery & Risk Solutions, LLC, collectively (DRS), is a leading provider of disaster response and recovery solutions, specializing in helping organizations prepare for and navigate the aftermath of disasters like fires, floods, and hurricanes. They offer a range of services including customized disaster preparedness planning and mitigation, real-time coordination during crises, and post-loss insurance and FEMA recovery guidance. DRS is committed to partnering with clients for effective recovery, helping to ensure organizations are well-prepared and resilient in the face of unforeseen disasters.
Read More
Life Insurance
PR Newswire | January 10, 2024
illumifin, a leading third-party insurance administration and technology provider, today announced it has acquired Administrative Partners of America (APA), the Third-Party Administrator (TPA) of AmeriLife, a national leader in developing, marketing, and distributing life and health insurance, annuities, and retirement planning solutions.
As one of the largest independent marketing organizations (IMO) in the U.S., AmeriLife and APA administer approximately 230,000 policies that generate $3.1 billion of premiums in life insurance, annuities and Medicare Supplement products annually. APA employs nearly 200 associates in Clearwater, Florida, and Salt Lake City, Utah, all of whom will transition to illumifin as part of the sale.
Peter Goldstein, President and Chief Executive Officer of illumifin, commented, "This is our second life and annuities acquisition that complements our existing TPA business and further transforms illumifin. We are constantly identifying new opportunities that will enhance our value proposition and make us a key strategic partner to our clients. AmeriLife has a solid platform with key client overlap that strengthens our relationships and opens the door for significant expansion opportunities. We are very excited to build a partnership with AmeriLife to help support their future growth efforts."
Scott R. Perry, Chairman and Chief Executive Officer of AmeriLife, added, "illumifin is a great home for our TPA operations, and APA's customers will benefit greatly from access to a broad set of capabilities and scalable services across all lines of business. We're equally as excited to begin a new era of partnership with illumifin, and – together with our carrier partners – introduce new products to market, fuel our collective growth, and continue transforming our industry for years to come."
illumifin was formed by Abry Partners, a leading Boston-based private equity firm, and Hoplon Capital, an asset manager focused on digital transformation and disruption.
About illumifin
illumifin provides third party administration and technology services to individual and group insurers. The company, launched in 2021, blends insurance industry knowledge, technology leadership and operational execution to prepare insurers for the digital future. illumifin is a diverse, passionate and empowered team of insurance specialists committed to the growth and success of its customers. With illumifin, there's a brighter future.
About AmeriLife
AmeriLfe's strength is its mission: to provide insurance and retirement solutions to help people live longer, healthier lives. In doing so, AmeriLife has become recognized as a leader in developing, marketing, and distributing life and health insurance, annuities, and retirement planning solutions to enhance the lives of pre-retirees and retirees across the United States. For more than 50 years, AmeriLife has partnered with top insurance carriers to provide value and quality to customers served through a distribution network of over 300,000 insurance agents and advisors and 120 marketing organizations and insurance agency locations nationwide.
About Abry Partners
Abry is one of the most experienced and successful sector-focused private equity investment firms in North America. Since its founding in 1989, the firm has completed over $90 billion of leveraged transactions and other private equity or preferred equity placements. Currently, the firm manages over $5 billion of capital across its active funds.
About Hoplon Capital
Hoplon pursues proprietary investments focused on the digital economy that are disruptive in their respective end markets including insurance, financial services, IT and consulting services, healthcare, digital infrastructure and media industries.
Read More